Pharmacovigilance of Lutetium Lu-177 PSMA-617 Versus PARP Inhibitors in metastatic Castration Resistant Prostate Cancer: A FAERS-Based Analysis
International Journal of Radiation Oncology*Biology*Physics · 2026-05 · 125 (1) · e14
DOI: 10.1016/j.ijrobp.2026.02.030 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Radiation Oncology*Biology*Physics, 2026-05. Verfasst von M.A. Ganiyani und 10 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Ganiyani, M., Sheraz, A., Syed, D., Nagendran, A., Avudaiappan, A. P., Abdalla, A., Pustake, M., Kaiser, A., Manoharan, M., Mehta, M., & Garje, R. (2026). Pharmacovigilance of Lutetium Lu-177 PSMA-617 Versus PARP Inhibitors in metastatic Castration Resistant Prostate Cancer: A FAERS-Based Analysis. International Journal of Radiation Oncology*Biology*Physics, 125(1), e14. https://doi.org/10.1016/j.ijrobp.2026.02.030
Vancouver
Ganiyani M, Sheraz A, Syed D, Nagendran A, Avudaiappan AP, Abdalla A, et al. Pharmacovigilance of Lutetium Lu-177 PSMA-617 Versus PARP Inhibitors in metastatic Castration Resistant Prostate Cancer: A FAERS-Based Analysis. International Journal of Radiation Oncology*Biology*Physics. 2026;125(1):e14. doi:10.1016/j.ijrobp.2026.02.030
BibTeX
@article{Ganiyani2026,
author = {Ganiyani, M.A. and Sheraz, A. and Syed, D.H. and Nagendran, A. and Avudaiappan, A. Pon and Abdalla, A. and Pustake, M. and Kaiser, A. and Manoharan, M. and Mehta, M.P. and Garje, R.},
title = {Pharmacovigilance of Lutetium Lu-177 PSMA-617 Versus PARP Inhibitors in metastatic Castration Resistant Prostate Cancer: A FAERS-Based Analysis},
journal = {International Journal of Radiation Oncology*Biology*Physics},
year = {2026},
volume = {125},
number = {1},
pages = {e14},
doi = {10.1016/j.ijrobp.2026.02.030}
}
EUVIMED